NFE2L2 and gastric neoplasm: The first demonstration by Ramos-Gomez et al. showed that the incidence of gastric tumors was significantly increased in nrf2-/- mice following B[a]P treatment and B[a]P-DNA adduct levels were concomitantly increased in these mutant mice [52,102].